RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

Background: Severe acute respiratory syndrome coronavirus 2 (SARS−CoV−2) infections and the resulting disease, coronavirus disease 2019 (COVID−19), have spread to millions of people globally. Multiple vaccine candidates are under development, but no vaccine is currently available. Methods: Healthy a...

詳細記述

保存先:
書誌詳細
出版年:medRxiv
主要な著者: Walsh, Edward E., Frenck, Robert, Falsey, Ann R., Kitchin, Nicholas, Absalon, Judith, Gurtman, Alejandra, Lockhart, Stephen, Neuzil, Kathleen, Mulligan, Mark J, Bailey, Ruth, Swanson, Kena A, Li, Ping, Koury, Kenneth, Kalina, Warren, Cooper, David, Fontes-Garfias, Camila, Shi, Pei-Yong, Türeci, Özlem, Thompkins, Kristin R, Lyke, Kirsten E., Raabe, Vanessa, Dormitzer, Philip R, Jansen, Kathrin U, Sahin, Uğur, Gruber, William C.
フォーマット: Artigo
言語:Inglês
出版事項: Cold Spring Harbor Laboratory 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444302/
https://ncbi.nlm.nih.gov/pubmed/32839784
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1101/2020.08.17.20176651
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料